6794-69-0

Basic information

• Product Name: 4-Phenyl-1,3-dihydro-imidazol-2-one
• Synonyms: 4-Phenyl-1,3-dihydro-imidazol-2-one;4-phenyl-1,3-dihydro-2H-imidazol-2-one(SALTDATA: FREE);4-phenyl-1,3-dihydro-2H-imidazol-2-one;MFCD00518909;1,3-dihydro-4-phenyl-2H-Imidazol-2-one
• CAS NO: 6794-69-0
• Molecular Formula: C₉H₈N₂O
• Molecular Weight: 160.17262
• Mol File: 6794-69-0.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Phenyl-1,3-dihydro-imidazol-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Phenyl-1,3-dihydro-imidazol-2-one(6794-69-0)
• EPA Substance Registry System: 4-Phenyl-1,3-dihydro-imidazol-2-one(6794-69-0)

Safety Data

• Hazardous Substances Data: 6794-69-0(Hazardous Substances Data)

Usage

General Description

4-Phenyl-1,3-dihydro-imidazol-2-one is a chemical compound with a molecular formula C10H10N2O. It is a derivative of imidazolone and contains a phenyl group attached to the carbon atom in position 4 of the imidazolone ring. 4-Phenyl-1,3-dihydro-imidazol-2-one is used in organic synthesis and pharmaceutical research as a building block or starting material for the synthesis of various bioactive compounds and pharmaceuticals. It has also been investigated for its potential biological activities, including its role as a GABA receptor agonist and its neuroprotective effects. Additionally, it has been studied for its potential application in the treatment of anxiety and other neurological disorders.

Upstream product

• 89-24-7 5-phenylimidazolidine-2,4-dione 
• 92809-78-4 2-oxo-5-phenyl-2,3-dihydro-1H-imidazole-4-carboxylic acid ethyl ester 
• 88419-01-6 3-(2-oxo-2-phenylethyl)thiazolidine-2,4-dione 
• 98-86-2 acetophenone 
• 57-13-6 urea 
• 70-11-1 α-bromoacetophenone 
• 593-75-9 methyl isocyanate 
• 698-16-8 benzohydroximoyl chloride 
• 5468-37-1 2-aminoacetophenone hydrochloride 
• 97567-79-8 2-amino-4-t-butyloxazole 
• 5918-93-4 1,3-dihydroimidazolone 
• 591-50-4 iodobenzene 
• 88419-13-0 2,4-dioxo-3-thiazolidinylmethyl phenyl ketone azine 
• 100-97-0 hexamethylenetetramine 

Downstream Products

• 27129-49-3 4-phenylimidazolidin-2-one 
• 161468-67-3 Ethyl 2,3-dihydro-2-oxo-4-phenyl-1H-imidazole-1-carboxylate 
• 84039-96-3 1-benzoyl-3-formylurea 
• 93782-04-8 1,3-Dihydro-4-phenyl-1-(phenylmethyl)-2H-imidazol-2-one 
• 83229-99-6 1-benzyl-5-phenyl-4-imidazolin-2-one 
• 161468-69-5 2,3-Dihydro-2-oxo-5-phenyl-1H-imidazole-1-carboxylic acid 1,1-dimethylethyl ester 
• 1026743-92-9 2-Oxo-4-phenyl-3-propyl-2,3-dihydro-imidazole-1-carboxylic acid ethyl ester 
• 1027302-96-0 3-Methoxycarbonylmethyl-2-oxo-4-phenyl-2,3-dihydro-imidazole-1-carboxylic acid ethyl ester 
• 1025919-95-2 3-Benzyl-2-oxo-4-phenyl-2,3-dihydro-imidazole-1-carboxylic acid ethyl ester 
• 1026573-85-2 3-Benzyl-2-oxo-5-phenyl-2,3-dihydro-imidazole-1-carboxylic acid tert-butyl ester 
• 161468-68-4 2-Oxo-4-phenyl-1H-imidazole-1,3(2H)-dicarboxylic acid 1-ethyl-3-(1,1-dimethylethyl) ester 
• 1026342-77-7 3-(3-Ethoxycarbonyl-propyl)-2-oxo-4-phenyl-2,3-dihydro-imidazole-1-carboxylic acid ethyl ester 
• 1078715-71-5 5-phenyl-4-phenylazo-3-imidazolin-2-one 

Relevant articles and documents

CYCLIC N-CARBOXAMIDE COMPOUNDS USEFUL AS HERBICIDES

Disclosed are compounds of Formula (1), including all stereoisomers, N-oxides, and salts thereof, (Formula (1)) wherein G, J, Q1, R4, Y2, Q2, R5 and Y1 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula (1) and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.

Phenacyl esters of acetic acid derivatives and their application for the synthesis of 2-oxo-4-phenyl-5-(phenylhydrazono)-2,5-dihydro-furan-3-derivatives

(Chemical Equation Presented) Coupling of various substituted phenacyl acetates 1 and diazonium salts 3 was studied. If the phenacyl acetates were substituted by an electronaceptor group such as CN or COOEt 3-substituted phenyl-5-(phenyl-hydrazono)-5H-fur

ARYLSULFONYLIMIDAZOLONE DERIVATIVES AS AN ANTITUMOR AGENT

The present invention relates to a novel arylsulfonylimidazolone derivative represented by the following formula (I) which shows a superior antineoplastic activity in contrast to the known sulfonylurea antitumor agents as well as little side effect: and its pharmaceutically acceptable salt and stereoisomer, in which +E,uns - -+EE , R1, and R2 are as defined in the specification.